Impacts of National Reimbursement Drug Price Negotiation on drug accessibility, utilization, and cost in China: a systematic review
Abstract Objective National Reimbursement Drug Price Negotiation (NRDPN) refers to a government-led process of negotiating with pharmaceutical companies to reach reasonable prices for exclusive drugs covered by national reimbursement. Since 2016, the Chinese government has regularly implemented eigh...
保存先:
| 主要な著者: | , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BMC
2025-02-01
|
| シリーズ: | International Journal for Equity in Health |
| 主題: | |
| オンライン･アクセス: | https://doi.org/10.1186/s12939-025-02390-w |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|